Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study
Antonio Berruezo(Hospital Quirón Teknon), Lluı́s Mont(Hospital Clínic de Barcelona), Eduardo Arana‐Rueda(Hospital Universitario Virgen del Rocío), Diego Penela(Hospital Quirón Teknon), Juan Fernández‐Armenta(Hospital Universitario Puerta del Mar), Alonso Pedrote(Hospital Universitario Virgen del Rocío), S Prat(Universitat de Barcelona), Andrés Bodegas(Hospital de Cruces), Luís Tercedor(Hospital Universitario Virgen de las Nieves), Ignasi Anguera(Institut d'Investigació Biomédica de Bellvitge), David Andreu(Universitat Pompeu Fabra), Alberto Barrera(Hospital Clínico Universitario Virgen de la Victoria), Juan Acosta(Hospital Universitario Virgen del Rocío), Rosario J. Perea(Hospital Clínic de Barcelona)
Cited by 69
Related Papers
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
|Journal of the American College of Cardiology|2013|631
Pulmonary Sarcoidosis: Typical and Atypical Manifestations at High-Resolution CT with Pathologic Correlation
|Radiographics|2010|490
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
|EP Europace|2019|461
Gender Differences in Clinical Manifestations of Brugada Syndrome
|Journal of the American College of Cardiology|2008|280